Introduction
Monitoring of hemostasis parameters like PT is substantial in many clinical settings, especially in cases of extensive surgery, dialysis or innate disorders of haemostasis 1 . Haemostasis monitoring also has primary significance in research perspectives such as in the cases of innate coagulation disorders and hemostatic effect of drugs with inflammatory potency 2 . This is because the haemostasis parameters can drastically change within the lapse of a few minutes due to exposure of patients' haemostatic system to large disturbances such as anticoagulation or haemo-dilution. Furthermore, undesired interactions with blood to artificial surfaces may lead to coagulation activation, blood platelet aggregation or proinflammatory effects. In these conditions frequent monitoring of the patients' haemostasis status is often crucial for proper therapeutic directions and decisions 3, 4 . For gaining overview of the plasmatic coagulation system, PT test is clinical standard assay. PT assay can detect the extrinsic part of the plasmatic coagulation cascade such as coagulation factors VII, X, V and II [5] [6] [7] [8] . Accurate monitoring of hemostatic effects is a huge stress for healthcare providers 9 .
QCM is gaining popularity for pharmaceuticals 10 and clinical studies by using suitable sensor thin films 11, 12 . It is popular due to its costeffectiveness and robustness as compared with its counterparts 13 .
QCM-D has an outstanding potential for haemostasis in the perspectives of clinical POC settings. It could measure the complete coagulation process, starting from fibrin formation, giving PT information, yielding total coagulation point and kinetics after total coagulation. To date, literature of PT studies on QCM-D platform includes studies on whole blood samples rather than on plasma applications 14, 15 . But QCM-D platform as the better alternative to that of standard mechanical coagulometer's ('gold standard') for PT
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Materials and Methods

Reagents and chemicals
Thromborel S was purchased from Siemens Health care/Dade Behring, Germany. Thromborel S was reconstituted with the 10 mL deionized water and kept at 37 °C for 30 minutes prior to using it. It was stored according to the manufacturer directions. HeparinNatrium-25000-(Ratiopharm) dilutions were made in 50 mM TRIS buffer (pH 7.4). Coagulation reference was purchased from
Technoclone gmbH (Austria). Afterwards, this transparent and homogenous polymer was further diluted with 700 µL acetone prior to spin coating onto the front electrode of each QCM.
QCM thin films
QCM electrodes were washed with N-methyl pyrrolidone followed by further cleaning with acetone. After cleaning of QCMs, 15 μl of diluted polymer was spin coated at 6000 rpm for 100 seconds onto the large electrode of each QCM. The thin film height (a 10 nm) on each QCM was controlled by QCM-D (qCell T). These QCMs (having thin films) were further kept under UV for 2.5 hours for achieving rigid sensor thin films for these measurements. Afterwards, these QCMs were either subjected to PT measurements on QCM-D or kept in the desiccator for storage prior to PT measurements on QCM-D.
Human plasma samples
For human plasma samples, whole blood samples from healthy human donors were received as the donation from the university hospital, Tuebingen, Germany. These fresh blood samples were gathered in tubes having 1.0 ml of 0.106 mol l-1 citrate. These samples were further centrifuged at 2500 x G for 15 minutes at room temperature to achieve platelets poor plasma (PPP) for present studies. For clarity, word 'plasma' or abbreviation PPP have been used throughout the manuscript rather than whole word 'platelets poor plasma'.
PT QCM-D measurements
QCMs were carefully inserted into the measurement unit of QCM-D and were calibrated at 37 °C to achieve a stable baseline. Plasma 
PT mechanical coagulometer 'Gold Standard' measurements
PT measurements for plasma samples were carried out on mechanical coagulometer in parallel to QCM-D's by employing 100 µl of the according to plasma sample and 200 µl of thromborel with same incubation times and temperature.
Results and Discussions
QCM-D devices are gaining popularity due to their unique ultrasensitivity 20 towards mass, viscosity or density of wetting liquids.
They produce sensor signals in the form of frequency and dissipation shifts 21, 22 . QCMs are also termed as Thickness Shear Mode
Transducers because a standing mechanical shear wave within the quartz is produced on applying alternating voltage to the electrodes of QCM. This half wavelength is equal to the thickness of the quartz.
Surface morphology of sensor film
SEM image of sensor thin film on QCM demonstrated fine texture and flat surface morphology explained in recent report 19 . Surface morphology is suitable for PT studies for plasma.
PT-QCM-D exemplary curves
After studies of surface morphology of thin films, the QCMs sensor thin films were subjected to human plasma samples for PT Additionally, heparin doses affect the kinetics for each plasma sample, which is observed in the form of PT and total coagulation points. The resultant measurement curves are further governed by the visco-elastic and hydrophobic properties of sensor thin film employed. Higher doses of heparin within same plasma sample of healthy donor produce longer kinetics in the terms of longer PT and total coagulation points. On the other hand, the heparin doses don't have any effect on the overall frequency and dissipation shifts which can be seen from the curves of different doses of heparin in figure 2.
PT-QCM-D vs PT-'gold standard'
Application of more real samples of human plasma samples for PT assay on QCM-D platform is substantial due to highly complex nature of human real plasma samples 24 . Figure 3 depicts a plot for comparing tQCM (where "t" is PT on QCM) with tCoag (where "t" is PT on 'gold standard'). This plot contains the data of human plasma samples (n=20) with different doses of heparin. Correlation between the two techniques is promising and within analytical limits of deviations. A promising correlation line is passing through the origin.
0.00 -1.00 IU/ml heparin doses in plasma samples yielded promising R 2 values of 0.97, while 2.00 IU/ml heparin yielded R 2 of 0.95.
Figure 3: PT on QCM-D (tQCM-D) of human plasma plotted against PT obtained from a mechanical coagulometer (tCoag). Plasma samples with different heparin doses are given with appropriate symbols (n=20 plasma samples for each heparin dose). Each data point is mean and ±
SD of three measurements
The data in each case of plasma sample is within analytical deviation limits and is on the ideal correlation line. Plasma samples (n=20)
having 0.00, 1.00, and 2.00 IU/ml doses of heparin yielded PT ranges of 15.5±2.37, 25.5±3, and 36±7 seconds respectively, on both techniques. The wide range of PT at 2.00 IU/ml doses of heparin is due to highly complex nature of human plasma and binding variation among different individuals at the higher dose of heparin. The binding of highly complex supra-molecules of heparin to plasma samples with different doses are different and produced a spread in the results of PT at higher dose. 
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